(Q57911034)

English

Hepatocellular carcinoma in a North American population: Does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis?

scientific article published on 25 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis? (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Mustafa R Bashir

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Matthew S Davenport

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Tracy A Jaffe

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Lisa M Ho

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Daniel T Boll

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Elmar M Merkle

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

25 September 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Journal of Magnetic Resonance Imaging

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

37

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

398-406

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

[Diagnosis of focal liver lesions in cirrhotic patients: comparison of contrast-enhanced ultrasound using sulphur hexafluoride (SF6) microbubbles and MRI using Gd-EOB-DTPA].

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Gadoxetic acid-enhanced MRI versus multiphase multidetector row computed tomography for evaluating the viable tumor of hepatocellular carcinomas treated with image-guided tumor therapy.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging?

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Fast 3D dynamic MR imaging of the liver with MR SmartPrep: comparison with helical CT in detecting hypervascular hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double art

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23818

21 January 2018

Identifiers

10.1002/JMRI.23818

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23011874%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57911034&oldid=2121187455"